Since modulating the expression of these genes is important for cancer therapy, we examined the possibility of downregulating SNAIL expression and upregulating NEUROD1 and HNF4 expression in a hypoxia-dependent manner using Cas9/dCas9 gene regulators. The gene discussed is NEUROD1; the disease is cancer.